nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Infection—Ifosfamide—testicular cancer	0.0031	0.0031	CcSEcCtD
Zanamivir—Ill-defined disorder—Cisplatin—testicular cancer	0.00305	0.00305	CcSEcCtD
Zanamivir—Skin disorder—Ifosfamide—testicular cancer	0.00303	0.00303	CcSEcCtD
Zanamivir—Feeling abnormal—Bleomycin—testicular cancer	0.003	0.003	CcSEcCtD
Zanamivir—Vomiting—Chlorambucil—testicular cancer	0.003	0.003	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—testicular cancer	0.00299	0.00299	CcSEcCtD
Zanamivir—Anorexia—Ifosfamide—testicular cancer	0.00297	0.00297	CcSEcCtD
Zanamivir—Malaise—Cisplatin—testicular cancer	0.00297	0.00297	CcSEcCtD
Zanamivir—Decreased appetite—Dactinomycin—testicular cancer	0.00296	0.00296	CcSEcCtD
Zanamivir—Diarrhoea—Vinblastine—testicular cancer	0.00295	0.00295	CcSEcCtD
Zanamivir—Fatigue—Dactinomycin—testicular cancer	0.00293	0.00293	CcSEcCtD
Zanamivir—Pain—Dactinomycin—testicular cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—testicular cancer	0.0029	0.0029	CcSEcCtD
Zanamivir—Urticaria—Bleomycin—testicular cancer	0.0029	0.0029	CcSEcCtD
Zanamivir—Body temperature increased—Bleomycin—testicular cancer	0.00288	0.00288	CcSEcCtD
Zanamivir—Dizziness—Vinblastine—testicular cancer	0.00285	0.00285	CcSEcCtD
Zanamivir—Convulsion—Cisplatin—testicular cancer	0.00285	0.00285	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00284	0.00284	CcSEcCtD
Zanamivir—Myalgia—Cisplatin—testicular cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Feeling abnormal—Dactinomycin—testicular cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Nausea—Chlorambucil—testicular cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Ill-defined disorder—Etoposide—testicular cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Anxiety—Cisplatin—testicular cancer	0.00279	0.00279	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Dyspnoea—Ifosfamide—testicular cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Discomfort—Cisplatin—testicular cancer	0.00277	0.00277	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—testicular cancer	0.00276	0.00276	CcSEcCtD
Zanamivir—Vomiting—Vinblastine—testicular cancer	0.00274	0.00274	CcSEcCtD
Zanamivir—Malaise—Etoposide—testicular cancer	0.00272	0.00272	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—testicular cancer	0.00271	0.00271	CcSEcCtD
Zanamivir—Decreased appetite—Ifosfamide—testicular cancer	0.00271	0.00271	CcSEcCtD
Zanamivir—Headache—Vinblastine—testicular cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Body temperature increased—Dactinomycin—testicular cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Abdominal pain—Dactinomycin—testicular cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Fatigue—Ifosfamide—testicular cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Anaphylactic shock—Cisplatin—testicular cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Hypersensitivity—Bleomycin—testicular cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00268	0.00268	CcSEcCtD
Zanamivir—Infection—Cisplatin—testicular cancer	0.00267	0.00267	CcSEcCtD
Zanamivir—Pain—Ifosfamide—testicular cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Loss of consciousness—Etoposide—testicular cancer	0.00265	0.00265	CcSEcCtD
Zanamivir—Cough—Etoposide—testicular cancer	0.00263	0.00263	CcSEcCtD
Zanamivir—Asthenia—Bleomycin—testicular cancer	0.00262	0.00262	CcSEcCtD
Zanamivir—Convulsion—Etoposide—testicular cancer	0.00261	0.00261	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Zanamivir—Skin disorder—Cisplatin—testicular cancer	0.00261	0.00261	CcSEcCtD
Zanamivir—Asthma—Methotrexate—testicular cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Feeling abnormal—Ifosfamide—testicular cancer	0.00257	0.00257	CcSEcCtD
Zanamivir—Nausea—Vinblastine—testicular cancer	0.00256	0.00256	CcSEcCtD
Zanamivir—Anorexia—Cisplatin—testicular cancer	0.00256	0.00256	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00255	0.00255	CcSEcCtD
Zanamivir—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00255	0.00255	CcSEcCtD
Zanamivir—Discomfort—Etoposide—testicular cancer	0.00254	0.00254	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00253	0.00253	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—testicular cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Hypersensitivity—Dactinomycin—testicular cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Confusional state—Etoposide—testicular cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Urticaria—Ifosfamide—testicular cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Abdominal pain—Ifosfamide—testicular cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Body temperature increased—Ifosfamide—testicular cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Anaphylactic shock—Etoposide—testicular cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Infection—Etoposide—testicular cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Asthenia—Dactinomycin—testicular cancer	0.00244	0.00244	CcSEcCtD
Zanamivir—Asthma—Epirubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Influenza—Epirubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Neutropenia—Methotrexate—testicular cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Dyspnoea—Cisplatin—testicular cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Skin disorder—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Zanamivir—Anorexia—Etoposide—testicular cancer	0.00235	0.00235	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00234	0.00234	CcSEcCtD
Zanamivir—Decreased appetite—Cisplatin—testicular cancer	0.00234	0.00234	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—testicular cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Diarrhoea—Dactinomycin—testicular cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Vomiting—Bleomycin—testicular cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Rash—Bleomycin—testicular cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Pain—Cisplatin—testicular cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Dermatitis—Bleomycin—testicular cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Hypersensitivity—Ifosfamide—testicular cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00229	0.00229	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Asthenia—Ifosfamide—testicular cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Feeling abnormal—Cisplatin—testicular cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Dyspnoea—Etoposide—testicular cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Nausea—Bleomycin—testicular cancer	0.00217	0.00217	CcSEcCtD
Zanamivir—Vomiting—Dactinomycin—testicular cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Rash—Dactinomycin—testicular cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Decreased appetite—Etoposide—testicular cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Diarrhoea—Ifosfamide—testicular cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Body temperature increased—Cisplatin—testicular cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Fatigue—Etoposide—testicular cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Pain—Etoposide—testicular cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Haemoglobin—Methotrexate—testicular cancer	0.00209	0.00209	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—testicular cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Dizziness—Ifosfamide—testicular cancer	0.00206	0.00206	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Zanamivir—Feeling abnormal—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Zanamivir—Nausea—Dactinomycin—testicular cancer	0.00202	0.00202	CcSEcCtD
Zanamivir—Gastrointestinal pain—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Vomiting—Ifosfamide—testicular cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Hypersensitivity—Cisplatin—testicular cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Rash—Ifosfamide—testicular cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Dermatitis—Ifosfamide—testicular cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—testicular cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Urticaria—Etoposide—testicular cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—testicular cancer	0.00195	0.00195	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—testicular cancer	0.00195	0.00195	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Zanamivir—Asthenia—Cisplatin—testicular cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Chills—Methotrexate—testicular cancer	0.00186	0.00186	CcSEcCtD
Zanamivir—Nausea—Ifosfamide—testicular cancer	0.00185	0.00185	CcSEcCtD
Zanamivir—Diarrhoea—Cisplatin—testicular cancer	0.00184	0.00184	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—testicular cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Zanamivir—Asthenia—Etoposide—testicular cancer	0.00177	0.00177	CcSEcCtD
Zanamivir—Chills—Epirubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Vomiting—Cisplatin—testicular cancer	0.00171	0.00171	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Rash—Cisplatin—testicular cancer	0.00169	0.00169	CcSEcCtD
Zanamivir—Dermatitis—Cisplatin—testicular cancer	0.00169	0.00169	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—testicular cancer	0.00168	0.00168	CcSEcCtD
Zanamivir—Ill-defined disorder—Methotrexate—testicular cancer	0.00168	0.00168	CcSEcCtD
Zanamivir—Malaise—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Zanamivir—Dizziness—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Zanamivir—Chills—Doxorubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Zanamivir—Nausea—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Zanamivir—Cough—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Zanamivir—Vomiting—Etoposide—testicular cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Agitation—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Rash—Etoposide—testicular cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—testicular cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Headache—Etoposide—testicular cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Zanamivir—Malaise—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Syncope—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Confusional state—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Cough—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—testicular cancer	0.00147	0.00147	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Zanamivir—Infection—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Zanamivir—Nausea—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Infection—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Cough—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Shock—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—testicular cancer	0.00131	0.00131	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Infection—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Pain—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Shock—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Zanamivir—Pain—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Urticaria—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Pain—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—testicular cancer	0.00099	0.00099	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—testicular cancer	0.000975	0.000975	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—testicular cancer	0.000944	0.000944	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—testicular cancer	0.00094	0.00094	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—testicular cancer	0.000937	0.000937	CcSEcCtD
Zanamivir—Rash—Methotrexate—testicular cancer	0.00093	0.00093	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—testicular cancer	0.000929	0.000929	CcSEcCtD
Zanamivir—Headache—Methotrexate—testicular cancer	0.000924	0.000924	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—testicular cancer	0.000916	0.000916	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—testicular cancer	0.000877	0.000877	CcSEcCtD
Zanamivir—Nausea—Methotrexate—testicular cancer	0.000876	0.000876	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—testicular cancer	0.000873	0.000873	CcSEcCtD
Zanamivir—Rash—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Zanamivir—Headache—Epirubicin—testicular cancer	0.000864	0.000864	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—testicular cancer	0.000844	0.000844	CcSEcCtD
Zanamivir—Nausea—Epirubicin—testicular cancer	0.000819	0.000819	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—testicular cancer	0.000812	0.000812	CcSEcCtD
Zanamivir—Rash—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Zanamivir—Headache—Doxorubicin—testicular cancer	0.0008	0.0008	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—testicular cancer	0.000758	0.000758	CcSEcCtD
